WhiteLab Genomics

WhiteLab Genomics is a biotechnology company focused on harnessing the power of artificial intelligence (AI) to accelerate the development of genomic medicines. Founded in 2019 and backed by Y-Combinator, the company operates at the intersection of biology and technology, utilizing advanced computational methods to analyze complex biological data. Their primary goal is to optimize drug design, enhancing both safety and efficacy in the development of new therapies.

The core of WhiteLab Genomics' offering is their proprietary AI-led framework known as ALFRED. This platform combines sophisticate…